Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOVC)
XETRA:NOVC
Holding DE:NOVC?
Track your performance easily
NOVC Stock Chart & Stats
Day’s Range€90.73 - €91.29
52-Week Range― - ―
Previous Close€91.19
Volume628.00
Average Volume (3M)N/A
Market Cap
kr307.46B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 02, 2023EPS Estimate
€0.61Last Dividend Ex-Date
Aug 18, 2023Dividend Yield1.06%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€137.01Price Target Upside51.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Novo Nordisk News
NOVC FAQ
What was Novo Nordisk’s price range in the past 12 months?
Currently, no data Available
What is Novo Nordisk’s market cap?
Currently, no data Available
When is Novo Nordisk’s upcoming earnings report date?
Novo Nordisk’s upcoming earnings report date is Nov 02, 2023 which is 297 days ago.
How were Novo Nordisk’s earnings last quarter?
Novo Nordisk released its earnings results on Aug 10, 2023. The company reported €0.578 earnings per share for the quarter, missing the consensus estimate of €0.614 by -€0.036.
Is Novo Nordisk overvalued?
According to Wall Street analysts Novo Nordisk’s price is currently Undervalued.
Does Novo Nordisk pay dividends?
Novo Nordisk pays a Annually dividend of €0.8 which represents an annual dividend yield of 1.06%. See more information on Novo Nordisk dividends here
What is Novo Nordisk’s EPS estimate?
Novo Nordisk’s EPS estimate is €0.61.
How many shares outstanding does Novo Nordisk have?
Currently, no data Available
What happened to Novo Nordisk’s price movement after its last earnings report?
Novo Nordisk reported an EPS of €0.578 in its last earnings report, missing expectations of €0.614. Following the earnings report the stock price went down -2.407%.
Which hedge fund is a major shareholder of Novo Nordisk?
Currently, no hedge funds are holding shares in DE:NOVC
---
Novo Nordisk Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€137.01 (51.01% Upside)
€137.01 (51.01% Upside)
Insider Transactions
Sold Shares
Worth kr29.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
81.54%
Trailing 12-Months
Asset Growth
28.24%
Trailing 12-Months
Company Description
Novo Nordisk
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
---
NOVC Stock 12 Month Forecast
Average Price Target
€137.01
▲(51.01% Upside)
Technical Analysis
Best Analysts Covering NOVC
1 Year
1 Year Success Rate
22/22 ratings generated profit
1 Year Average Return
+40.70%
reiterated a buy rating 12 months ago
Copying Emily Field's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.70% per trade.
---